These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
533 related items for PubMed ID: 6234628
1. [Combined bone marrow and skeletal scintigraphy in osseous and myelogenous diseases]. Hotze A, Löw A, Mahlstedt J, Wolf F. Rofo; 1984 Jun; 140(6):717-23. PubMed ID: 6234628 [Abstract] [Full Text] [Related]
2. [Significance of skeletal scintigraphy for oncological practice]. Kampmann H, Buchelt L. Rontgenblatter; 1983 Oct; 36(10):342-51. PubMed ID: 6227979 [Abstract] [Full Text] [Related]
3. Optimizing the performance and interpretation of bone scans. Muroff LR. Clin Nucl Med; 1981 Oct; 6(10S):P68-76. PubMed ID: 6271444 [No Abstract] [Full Text] [Related]
4. Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastases. Gulenchyn KY, Papoff W. Clin Nucl Med; 1987 Jan; 12(1):45-6. PubMed ID: 3815996 [Abstract] [Full Text] [Related]
5. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases. Limouris GS, Voliotopoulos V, Stavraka A, Vlahos L. Anticancer Res; 1997 Jan; 17(3B):1615-8. PubMed ID: 9179204 [Abstract] [Full Text] [Related]
13. [Comparison of skeletal scintigraphy and bone marrow scintigraphy in detection of osseous metastases]. Bathmann J, Moser E. Radiologe; 1995 Jan; 35(1):8-14. PubMed ID: 7892445 [Abstract] [Full Text] [Related]
14. [Local bone pain and osseous scintigraphic findings in patients with metastatic bone tumor]. Imaeda T, Iinuma G, Hirota K, Inoue A, Sone Y, Seki M, Suzuki M, Doi H. Kaku Igaku; 1988 Dec; 25(12):1319-27. PubMed ID: 3249457 [No Abstract] [Full Text] [Related]
15. [NMR tomography in plasmacytoma]. Linden A, Gückel C, Widder R, Jungehülsing M, Diehl V, Schicha H. Rofo; 1992 Jan; 156(1):83-8. PubMed ID: 1733480 [Abstract] [Full Text] [Related]
18. Bone and bone marrow scintigraphy in the diagnosis of neoplastic involvement of the skeletal system. A comparative analysis. Sacchi S, Marietta M, Rinaldi G, Pantusa M, Romani F, Zaniol P, Torelli U. J Nucl Med Allied Sci; 1987 Jan; 31(3):255-60. PubMed ID: 3694273 [No Abstract] [Full Text] [Related]
19. The value of bone marrow scintigraphy using 99mTc monoclonal antigranulocyte antibodies in complement to bone scintigraphy in detecting bone metastases from primary breast cancer. Prior JO, Barghouth G, Delaloye JF, Leyvraz S, Bischof Delaloye A. Nucl Med Commun; 2003 Jan; 24(1):29-36. PubMed ID: 12501017 [Abstract] [Full Text] [Related]